BOZE family office (FO) founded in 2009 with registered capital of RMB 300 million, manages owned assets worth of over RMB 4 billion. The FO has its headquarter in Beijing and foreign investment subsidiaries in Hong Kong. BOZE was founded to handle asset management and wealth succession for a single wealthy family. Over the years, BOZE has been working on improving every function of a FO and now is a comprehensive leading FO in China conceiving global perspectives. BOZE will continue to provide more families with access to its services and develop into an authentic domestic private MFO.
With a highly professional asset management team, BOZE allocates assets throughout primary and secondary markets in both China and other countries. Featuring investments in pharmaceuticals, consumer goods and TMT sectors, BOZE has constructed a product portfolio including equity investments in China and overseas markets, alternative investments, fixed income investments, customized investments and more. BOZE utilizes a meticulous investment management strategy and strict risk control system, guided by the asset allocation philosophy of safety, stability and low correlation, and the strategy of seeking balance and diversification with featured pharmaceuticals. From an independent, objective and professional perspective, BOZE has provided highly customized asset allocation solutions for wealthy families. As a practitioner of long-term fundamental value investment philosophy, Boze emphasizes the investment strategies around the circle of competence, fundamental research in-depth, long-term view, value investment, and high return-risk ratio.
BOZE proactively explores comprehensive functions of a FO such as family governance (family constitution and inheritance research), wealth protection (structure and tools) and family succession (successor education, family charity and quality life) and carefully carries out applicable methods. BOZE has already formed a unique FO business ecosystem.
In line with values such as a people-oriented approach, innovation, constant improvement and stronger families for a stronger nation, BOZE devotes itself to combining western advanced wealth management ideas with Chinese culture to become the pioneer in Chinese private MFO during the times of industrial transformation and upgrading and keep in tune with the changes of society and the market. BOZE will serve more high-net-worth individuals and wealthy families concerning systematic wealth protection, management and succession solutions, and instruct wealthy families to break the curse of “clogs to clogs in three generations.” BOZE will assist wealthy families pass their honor and wealth to future generations. May families and businesses prosper throughout the ages!
Professor Yu Hongru is the founder of BOZE FO, an expert in medicine and biochemistry, and a knowledgeable entrepreneur in high-tech who started technical innovation from the university laboratory.
Professor Yu Hongru has led a number of research and successfully developed several vital products including the "Deproteinized Calf Blood Serum Injection" and the "Hemocoagulase For Injection” whose sales rank at the forefront of domestic clinical medicine. He also founded the domestically renowned bio-pharmaceutical company - Jinzhou Aohong Pharmaceutical, and successfully carried out the industrial upgrading, making a big fortune. In Beijing, he established the BOZE FO, and with the “spirit of the craftsman”, he meticulously leads the team and spares no efforts to make BOZE the pioneer in Chinese-featured private MFO during times of industrial transformation and upgrading!
BOZE FO has been developing the global asset allocation method since 2013 following the investment philosophy that integrates western classical asset allocation ideas, Chinese characteristics and the company’s strengths. As a pioneer in family office asset management in China, BOZE has gained rich experience in domestic and foreign investment……
BOZE’s founding family earned its assets from the pharmaceutical industry. With the long-term, stable, and responsible investment philosophy, BOZE family office combines the characteristics of pharmaceutical with diversified industry strategies, sets its sights on long-term value, and takes investment in optimal sub-funds as the core strategy……
The investment research system of BOZE is composed of talented financial investors and pharmaceutical experts. The system now contains over 20 members, and the investment managers have an average investing experience of over 15 years in domestic and international large, non-private funds or in the pharmaceutical industry. The pharmaceutical expert team shows a deep understanding of domestic pharmaceutical industry policies, and can spot investment value from an industrial perspective. The asset allocation expert team is made up of accomplished people in the field who have years of practice in global asset allocation.
Since the Reform and Opening up of China 40 years ago, the society is in a time of stability and prosperity, and the private wealth industry has taken off. Private businesses are entering a slowing growth stage from the high-speed growth stage of years before, and it is time for founders to consider their successors.
The investment needs of Chinese families shift from sole asset appreciation to construction of a complete family wealth ecosystem including asset protection, tangible and intangible asset succession, and family governance.
After the founder of BOZE left manufacturing and dedicated to asset allocation, he saw the difficulties for private businesses to transform and innovate, and with the simple goal of solving asset management and inheritance of his own family, BOZE with spirit of craftsman meticulously created systematic planning and improvements on family governance, wealth protection and family succession. And gradually, BOZE mastered the relation between an ever-prosperous family and social, financial, human resource and cultural capital.
Intuition Capital, relying on the BOZE family office-one of the forerunners in the management practices of local Chinese families' wealth – was founded in 2021 and operated independently with a family-provided start-up.
Intuition Capital, in accordance with a core mentality of "value investment and long-term focus," combines investment and research and possesses in-depth knowledge on tapping into the market's high-grade assets while focusing and gradually expanding on our circle of competency.
根据《私募投资基金监督管理暂行办法》第四章第十四条规定:"私募基金管理人、私募基金销售机构不得向合格投资者之外的单位和个人募集资金,不得通过报刊、电台、电视、互联网等公众传播媒体或者讲座、报告会、分析会和布告、传单、手机短信、微信、博客和电子邮件等方式,向不特定对象宣传推介。"